Cardio-Antiarrythmics Flashcards
Class I Anti-arrythmics MOA
block fast inward Na channels
in conductive tissues of the heart
Class 1A agents (3)
Quinidine
Procainamide
Disopyramide
Class 1B agents (2)
Lidocaine
Mexiletine
Class 1C agents (2)
Propanefone
Flecainamide
Class I Anti-Arrythmics Uses
Ventricular dysrhythmias and/or digitalis or MI-induced arrythmia
Clinical applications of quinidine
refractory patients
to convert AFib or FLutter, Prevent recurrences of AFib, treat life-threatining ventricular arrythmias
Procainamide MOA
Physiolgical effects
blocks Na channels
blocks K channels
Slowed conduction, automaticity, excitability
Prolongs APD and refractoriness
Procainamide clinical uses
Acute treatment of:
reentrant SVT
A-Fib
Atrial flutter associated with WPW Syndrome
Life-threatening ventricular arrythmias
HAS TO BE DELIVERED SLOWLY OVER TIME
Procainamide Adverse Effects
Cardiac - arrythmia aggravation, torsades, long QT syndrome
Non-cardiac: SLE-like syndrome, GI nausea and vomiting
Lidocaine Clinical Uses
Pharmacologic implications
second choice for life-threatening/sympotmatic arrythmias
Extensive 1st pass metabolism - needs IV use with multiple loading doses and a maintenance infusion
Propafenone MOA
Physiological effects
strong inhibitor of Na channels
strong effects on phase 0 depolarization
lengthened QRS and APD, PR as well
Propanefone clinical uses
atrial arrythmias, PSVT
ventricular arrythmias in patient with no or minimal heart disease and PRESERVED VENTRICULAR FUNCTION
Flecainide MOA
Clinical use
strong Na inhibitor
severely slows ventricular conduction
REFRACTORY life-threatening ectopic ventricular arrythmia
Class II Anti-arrythmics MOA
Beta-adrenergic antagonists
Decreased SA node automaticity, Decreased AV node conduction, Decreased Ventricular contractility
Class II Anti-arrythmics Clinical uses
only drugs found to what?
supra-ventricular tachycardias d/t increased sympathetic activity
preventing sudden death in patients with prior MI